
News|Articles|February 1, 2002
Pipeline Preview
as reported February 1, 2002
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicare Advantage enrollees more likely to leave after new complex diagnosis
2
FDA approves brepocitinib for rare skin disease
3
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
4
USPS Woes Continue: Health Plans, Be Prepared
5

























